Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
This study has been terminated in response to a reported serious adverse event (SAE). The sponsor's assessment of the limited data available at the time of the initial SAE report was that the SAE may alter the potential benefit - risk profile of the study medication.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects must have a diagnosis of osteoarthritis based on the American College of Rheumatology criteria confirmed by an X-ray
Subjects must be willing and able to stop all current pain therapy for the duration of the study
Subjects must be willing and able to complete a daily diary
You may not be if
BMI of \>39 kg/m2
Known allergy or hypersensitivity to naproxen
Any condition or medical history that might interfere with the subject's ability to complete the study visits and assessments
Clareo Health | A Study Of The Safety And Efficacy Of PF-04191834 In Patients With Osteoarthritis Of The Knee
